NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that a jury has found it guilty of infringing Enzo Biochem's patents and awarded Enzo $48.6 million.
NEW YORK (GenomeWeb News) – Enzo Biochem announced after the close of the market Monday that its fourth-quarter revenues declined a little more than 1 percent year over year as the firm began a realignment of its operations aimed at reducing its cash burn.
Qiagen has been awarded US Patent No. 8,247,545, "Device and a process for the isolation of nucleic acids."
Metin Colpan is named as inventor on the patent.
Roche, Life Technologies, and Gen-Probe have each filed responses to a lawsuit brought against them by Enzo Life Sciences claiming that various nucleic acid probe-based research and diagnostics products infringe a patent owned by Enzo.
NEW YORK (GenomeWeb News) – Enzo Biochem has issued 275,000 shares of its common stock to its law firm as payment for legal fees, the New York-based company disclosed in a document filed on Friday with the US Securities and Exchange Commission.
NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market on Monday that revenues for the fiscal third quarter inched up slightly year over year, but that net loss increased.
In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.
